Fundraising FoxCadex Genomics
1 known investors
Find your way into Cadex Genomics
Sign up to see every warm intro you have to Cadex Genomics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Cadex Genomics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Cadex Genomics develops blood-based diagnostic assays for cancer patients. Its product Alibrex is a real-time therapy monitoring blood test that measures changes in circulating tumor DNA to assess whether a stage IV cancer patient's treatment is effective within about 12 days of the first dose, regardless of tumor or therapy type.
Investors · 1
Frequently asked questions
- What does Cadex Genomics do?
- Cadex Genomics develops blood-based diagnostic assays for cancer patients. Its product Alibrex is a real-time therapy monitoring blood test that measures changes in circulating tumor DNA to assess whether a stage IV cancer patient's treatment is effective within about 12 days of the first dose, regardless of tumor or therapy type.
- Who are Cadex Genomics's investors?
- Cadex Genomics's investors include BioGenerator Ventures.